

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.50606659 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.50606659 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.50606659 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.50606659 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.50606659 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.50606659 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.25825398 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.25825398 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49107659 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46518711 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.35335663 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32809949 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.30420251 |
| 14 | regulation of mononuclear cell migration (GO:0071675) | 4.15737728 |
| 15 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.12858670 |
| 16 | rhodopsin mediated signaling pathway (GO:0016056) | 4.01457959 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.96597623 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96356622 |
| 19 | apoptotic cell clearance (GO:0043277) | 3.90474823 |
| 20 | detection of other organism (GO:0098543) | 3.88441032 |
| 21 | detection of bacterium (GO:0016045) | 3.79831151 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70739939 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.69718235 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.63170550 |
| 25 | retinal cone cell development (GO:0046549) | 3.62069082 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61123255 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.57822340 |
| 28 | mannose metabolic process (GO:0006013) | 3.56214169 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51248693 |
| 30 | response to host immune response (GO:0052572) | 3.51248693 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.47883600 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.46492530 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.45975362 |
| 34 | positive regulation of interferon-alpha production (GO:0032727) | 3.43802527 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.43699543 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.24666462 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.23762543 |
| 38 | negative regulation of mast cell activation (GO:0033004) | 3.21662919 |
| 39 | response to host (GO:0075136) | 3.19454385 |
| 40 | response to host defenses (GO:0052200) | 3.19454385 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19454385 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.18249828 |
| 43 | leukocyte aggregation (GO:0070486) | 3.17109172 |
| 44 | regulation of integrin activation (GO:0033623) | 3.16660392 |
| 45 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.10578727 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10124992 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05566254 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02634694 |
| 49 | respiratory burst (GO:0045730) | 3.01515519 |
| 50 | immunoglobulin mediated immune response (GO:0016064) | 2.99664233 |
| 51 | detection of biotic stimulus (GO:0009595) | 2.97282650 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 2.95619738 |
| 53 | regulation of macrophage chemotaxis (GO:0010758) | 2.94731947 |
| 54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94201028 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 2.94201028 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.93771336 |
| 57 | phototransduction, visible light (GO:0007603) | 2.92307796 |
| 58 | microglial cell activation (GO:0001774) | 2.91530332 |
| 59 | cell adhesion mediated by integrin (GO:0033627) | 2.90602151 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 2.90341617 |
| 61 | neutrophil activation (GO:0042119) | 2.90195494 |
| 62 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.89532967 |
| 63 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.89075438 |
| 64 | barbed-end actin filament capping (GO:0051016) | 2.88912841 |
| 65 | wound healing, spreading of epidermal cells (GO:0035313) | 2.87677425 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87206894 |
| 67 | response to type I interferon (GO:0034340) | 2.86888752 |
| 68 | cellular extravasation (GO:0045123) | 2.86559994 |
| 69 | type I interferon signaling pathway (GO:0060337) | 2.85401775 |
| 70 | cellular response to type I interferon (GO:0071357) | 2.85401775 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83994994 |
| 72 | lipoprotein transport (GO:0042953) | 2.83492252 |
| 73 | positive regulation of p38MAPK cascade (GO:1900745) | 2.82372730 |
| 74 | phototransduction (GO:0007602) | 2.82315434 |
| 75 | regulation of guanylate cyclase activity (GO:0031282) | 2.82090870 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81565067 |
| 77 | macrophage activation (GO:0042116) | 2.81234107 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81203625 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80848346 |
| 80 | keratan sulfate catabolic process (GO:0042340) | 2.79437808 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72025868 |
| 82 | photoreceptor cell development (GO:0042461) | 2.70403509 |
| 83 | regulation of regulated secretory pathway (GO:1903305) | 2.70256589 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.70088809 |
| 85 | germinal center formation (GO:0002467) | 2.69961967 |
| 86 | basement membrane organization (GO:0071711) | 2.69080002 |
| 87 | positive thymic T cell selection (GO:0045059) | 2.68671604 |
| 88 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68619580 |
| 89 | protein carboxylation (GO:0018214) | 2.66328074 |
| 90 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.66328074 |
| 91 | response to peptidoglycan (GO:0032494) | 2.65422395 |
| 92 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65333008 |
| 93 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65256943 |
| 94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65256943 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.65184177 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.64377936 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.64035818 |
| 98 | hyaluronan catabolic process (GO:0030214) | 2.63482543 |
| 99 | positive regulation of lipid storage (GO:0010884) | 2.62581200 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61646004 |
| 101 | eye photoreceptor cell development (GO:0042462) | 2.61415952 |
| 102 | detection of visible light (GO:0009584) | 2.60885834 |
| 103 | regulation of antigen processing and presentation (GO:0002577) | 2.60060559 |
| 104 | response to interleukin-15 (GO:0070672) | 2.59406134 |
| 105 | negative regulation of lipid storage (GO:0010888) | 2.59275469 |
| 106 | lymphocyte chemotaxis (GO:0048247) | 2.59180016 |
| 107 | granulocyte activation (GO:0036230) | 2.58371321 |
| 108 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.58121844 |
| 109 | positive regulation of phagocytosis (GO:0050766) | 2.57677173 |
| 110 | negative regulation of phagocytosis (GO:0050765) | 2.57384814 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 2.56961610 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56525276 |
| 113 | positive regulation of macrophage cytokine production (GO:0060907) | 2.56118762 |
| 114 | detection of light stimulus (GO:0009583) | 2.55536581 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.55454159 |
| 116 | pinocytosis (GO:0006907) | 2.54476702 |
| 117 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.54090393 |
| 118 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.53646091 |
| 119 | response to thyroid hormone (GO:0097066) | 2.53305128 |
| 120 | positive regulation of leukocyte degranulation (GO:0043302) | 2.52334504 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 2.52002771 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51809475 |
| 123 | protein-chromophore linkage (GO:0018298) | 2.51131077 |
| 124 | tolerance induction (GO:0002507) | 2.50955300 |
| 125 | negative regulation of type 2 immune response (GO:0002829) | 2.50437026 |
| 126 | regulation of type 2 immune response (GO:0002828) | 2.49365060 |
| 127 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.49256982 |
| 128 | regulation of phagocytosis (GO:0050764) | 2.48513998 |
| 129 | defense response to protozoan (GO:0042832) | 2.47297356 |
| 130 | positive regulation of mast cell activation (GO:0033005) | 2.47155352 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.46559300 |
| 132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.45822797 |
| 133 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.44795971 |
| 134 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44271736 |
| 135 | amyloid precursor protein catabolic process (GO:0042987) | 2.44246989 |
| 136 | detection of light stimulus involved in visual perception (GO:0050908) | 2.43892911 |
| 137 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.43892911 |
| 138 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43766139 |
| 139 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.43346105 |
| 140 | glomerular visceral epithelial cell development (GO:0072015) | 2.43001023 |
| 141 | regulation of mast cell activation (GO:0033003) | 2.42721365 |
| 142 | positive regulation of type 2 immune response (GO:0002830) | 2.42590366 |
| 143 | amino sugar catabolic process (GO:0046348) | 2.42481589 |
| 144 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42032562 |
| 145 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.41803958 |
| 146 | positive regulation of interferon-beta production (GO:0032728) | 2.40123732 |
| 147 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39742315 |
| 148 | phagocytosis, recognition (GO:0006910) | 2.39575096 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.38079069 |
| 150 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.37233069 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.36762098 |
| 152 | myeloid dendritic cell differentiation (GO:0043011) | 2.36256670 |
| 153 | positive regulation of coagulation (GO:0050820) | 2.35081693 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.35020576 |
| 155 | complement activation, alternative pathway (GO:0006957) | 2.34852022 |
| 156 | negative regulation of interleukin-6 production (GO:0032715) | 2.34627854 |
| 157 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.34410475 |
| 158 | I-kappaB phosphorylation (GO:0007252) | 2.33805270 |
| 159 | regulation of macrophage cytokine production (GO:0010935) | 2.33078818 |
| 160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30573481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.93686599 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.79768188 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54645861 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24831782 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.12488830 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.11961659 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.11958546 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.82005865 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68165560 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67920494 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52459938 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48831340 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40094717 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36669900 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31166506 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26018494 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.12937334 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07987952 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03284118 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03146995 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.95493679 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88279475 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86379418 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84323824 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83476026 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81323525 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78084533 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76982628 |
| 29 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76089513 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67349254 |
| 31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65648961 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63755215 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63245496 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63141701 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57705952 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56265430 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55606321 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54989277 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54064337 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53222698 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52162494 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50093429 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48562429 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45745326 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44859825 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44105594 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42985344 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37167603 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36651804 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36186509 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.35550053 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.31647925 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31259478 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29502724 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28394827 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27964245 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27489818 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26719835 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26212993 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25996673 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25635907 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25435130 |
| 63 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24891448 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24473055 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24140336 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24132149 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.23899817 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22781406 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22735413 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22159650 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21260573 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20987596 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20185575 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18787148 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18771777 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18346387 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18014505 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17300828 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17172875 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15632254 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14600497 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13429888 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13077990 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12660670 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12147698 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11509411 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10996805 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10914023 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09307818 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09252366 |
| 91 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09031229 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09012244 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.08205289 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06969669 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06795903 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06293050 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06191613 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.05436985 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.05436985 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05361488 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04529209 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04396942 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03627104 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03535433 |
| 105 | MYB_26560356_Chip-Seq_TH1_Human | 1.03280732 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03146165 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02403066 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.02376404 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02088402 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01020513 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00823561 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00641673 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00600360 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99803943 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99444575 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99092587 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98795027 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97494742 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97074232 |
| 120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96626786 |
| 121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96480876 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95887641 |
| 123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95864077 |
| 124 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95552542 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95326393 |
| 126 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95213445 |
| 127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95011298 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94221263 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93575629 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93146586 |
| 131 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93040178 |
| 132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91873487 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91014108 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91014108 |
| 135 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90124982 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89171742 |
| 137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88319929 |
| 138 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88118400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.20683022 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.76667602 |
| 3 | MP0003303_peritoneal_inflammation | 3.23698363 |
| 4 | MP0009840_abnormal_foam_cell | 3.18604532 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.85564720 |
| 6 | MP0003436_decreased_susceptibility_to | 2.73095043 |
| 7 | MP0006082_CNS_inflammation | 2.61694172 |
| 8 | MP0005671_abnormal_response_to | 2.43163183 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.37543476 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.29595609 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.29201053 |
| 12 | MP0004510_myositis | 2.12402058 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.10925248 |
| 14 | MP0003172_abnormal_lysosome_physiology | 1.98941700 |
| 15 | MP0002419_abnormal_innate_immunity | 1.96759956 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.96694424 |
| 17 | MP0002090_abnormal_vision | 1.91005567 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.85882424 |
| 19 | MP0000343_altered_response_to | 1.82459071 |
| 20 | MP0001958_emphysema | 1.76872062 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.74143569 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.70850132 |
| 23 | MP0005360_urolithiasis | 1.69675933 |
| 24 | MP0003724_increased_susceptibility_to | 1.68253869 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.61644971 |
| 26 | MP0003075_altered_response_to | 1.58028718 |
| 27 | MP0005451_abnormal_body_composition | 1.56590918 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.55734482 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.51435259 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.50674951 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.50321883 |
| 32 | MP0005253_abnormal_eye_physiology | 1.49040354 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.45700204 |
| 34 | MP0003690_abnormal_glial_cell | 1.44693167 |
| 35 | MP0009785_altered_susceptibility_to | 1.44671699 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.43802489 |
| 37 | MP0003329_amyloid_beta_deposits | 1.43222190 |
| 38 | * MP0005025_abnormal_response_to | 1.42569744 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.42549501 |
| 40 | MP0003279_aneurysm | 1.40970195 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.38834615 |
| 42 | MP0005387_immune_system_phenotype | 1.38598173 |
| 43 | MP0001790_abnormal_immune_system | 1.38598173 |
| 44 | MP0003252_abnormal_bile_duct | 1.33305333 |
| 45 | MP0000858_altered_metastatic_potential | 1.32281256 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.32075409 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.31650314 |
| 48 | MP0003448_altered_tumor_morphology | 1.31466648 |
| 49 | MP0001324_abnormal_eye_pigmentation | 1.30071334 |
| 50 | * MP0000716_abnormal_immune_system | 1.29920787 |
| 51 | MP0005275_abnormal_skin_tensile | 1.29617909 |
| 52 | MP0008260_abnormal_autophagy | 1.28824648 |
| 53 | MP0004130_abnormal_muscle_cell | 1.28652203 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.28493118 |
| 55 | MP0009764_decreased_sensitivity_to | 1.27183332 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.27150083 |
| 57 | MP0008469_abnormal_protein_level | 1.22689343 |
| 58 | MP0008004_abnormal_stomach_pH | 1.21338993 |
| 59 | MP0003828_pulmonary_edema | 1.17819721 |
| 60 | MP0000920_abnormal_myelination | 1.17819203 |
| 61 | MP0003195_calcinosis | 1.16861372 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.16247714 |
| 63 | MP0005166_decreased_susceptibility_to | 1.15673269 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15150165 |
| 65 | MP0000750_abnormal_muscle_regeneration | 1.15000261 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.14815859 |
| 67 | MP0002254_reproductive_system_inflammat | 1.14618285 |
| 68 | * MP0002398_abnormal_bone_marrow | 1.13798437 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.12187952 |
| 70 | MP0000685_abnormal_immune_system | 1.11971781 |
| 71 | MP0009278_abnormal_bone_marrow | 1.10417947 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.10164326 |
| 73 | MP0000604_amyloidosis | 1.10093110 |
| 74 | MP0004883_abnormal_blood_vessel | 1.09641662 |
| 75 | MP0005197_abnormal_uvea_morphology | 1.08920894 |
| 76 | MP0010329_abnormal_lipoprotein_level | 1.08917334 |
| 77 | MP0004947_skin_inflammation | 1.08693692 |
| 78 | MP0001853_heart_inflammation | 1.06833502 |
| 79 | * MP0002723_abnormal_immune_serum | 1.05565353 |
| 80 | MP0001851_eye_inflammation | 1.05009267 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.03176287 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.02594024 |
| 83 | MP0005390_skeleton_phenotype | 1.01485620 |
| 84 | MP0003879_abnormal_hair_cell | 0.99874695 |
| 85 | MP0005195_abnormal_posterior_eye | 0.99408324 |
| 86 | MP0001800_abnormal_humoral_immune | 0.97285089 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.97090789 |
| 88 | MP0005023_abnormal_wound_healing | 0.97020699 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.96238415 |
| 90 | MP0002405_respiratory_system_inflammati | 0.95954302 |
| 91 | * MP0002429_abnormal_blood_cell | 0.95064161 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.95053300 |
| 93 | MP0000609_abnormal_liver_physiology | 0.94412429 |
| 94 | MP0000249_abnormal_blood_vessel | 0.94062663 |
| 95 | MP0010307_abnormal_tumor_latency | 0.93855319 |
| 96 | MP0001764_abnormal_homeostasis | 0.93819916 |
| 97 | MP0005164_abnormal_response_to | 0.93660927 |
| 98 | MP0003866_abnormal_defecation | 0.93402003 |
| 99 | MP0005165_increased_susceptibility_to | 0.92591043 |
| 100 | * MP0000689_abnormal_spleen_morphology | 0.92252491 |
| 101 | MP0008874_decreased_physiological_sensi | 0.91797957 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.89874556 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.89874556 |
| 104 | MP0005670_abnormal_white_adipose | 0.89522818 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.89132602 |
| 106 | MP0001542_abnormal_bone_strength | 0.88805363 |
| 107 | MP0001819_abnormal_immune_cell | 0.88730498 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.88016231 |
| 109 | MP0004272_abnormal_basement_membrane | 0.87741053 |
| 110 | MP0001756_abnormal_urination | 0.87683118 |
| 111 | MP0003091_abnormal_cell_migration | 0.87658993 |
| 112 | MP0005365_abnormal_bile_salt | 0.87254150 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.87076885 |
| 114 | * MP0002722_abnormal_immune_system | 0.87071828 |
| 115 | MP0002420_abnormal_adaptive_immunity | 0.86684892 |
| 116 | MP0002132_abnormal_respiratory_system | 0.83895403 |
| 117 | MP0005332_abnormal_amino_acid | 0.83875004 |
| 118 | MP0002933_joint_inflammation | 0.82900309 |
| 119 | MP0003795_abnormal_bone_structure | 0.82415884 |
| 120 | MP0003045_fibrosis | 0.81926513 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.81045645 |
| 122 | MP0005310_abnormal_salivary_gland | 0.80348585 |
| 123 | MP0009763_increased_sensitivity_to | 0.79808467 |
| 124 | MP0002971_abnormal_brown_adipose | 0.79703554 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.78547520 |
| 126 | MP0005503_abnormal_tendon_morphology | 0.78181507 |
| 127 | MP0005083_abnormal_biliary_tract | 0.77743522 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.75795601 |
| 129 | MP0001663_abnormal_digestive_system | 0.75774293 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.74160156 |
| 131 | MP0001873_stomach_inflammation | 0.73883501 |
| 132 | MP0005535_abnormal_body_temperature | 0.73726677 |
| 133 | MP0005388_respiratory_system_phenotype | 0.71587681 |
| 134 | MP0002133_abnormal_respiratory_system | 0.71587681 |
| 135 | MP0004858_abnormal_nervous_system | 0.71051694 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.68024491 |
| 137 | MP0004381_abnormal_hair_follicle | 0.66811656 |
| 138 | MP0001501_abnormal_sleep_pattern | 0.66708608 |
| 139 | MP0001849_ear_inflammation | 0.65906182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.59644427 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.28219262 |
| 3 | Pigmentary retinal degeneration (HP:0001146) | 4.93299420 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.90858707 |
| 5 | Axonal loss (HP:0003447) | 4.58673961 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.38109190 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.33553217 |
| 8 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.28554359 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.05143043 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.87389567 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.83516512 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.76250127 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72572172 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72572172 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72572172 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.69786836 |
| 17 | Dyschromatopsia (HP:0007641) | 3.68603266 |
| 18 | Chorioretinal atrophy (HP:0000533) | 3.67319403 |
| 19 | Retinal atrophy (HP:0001105) | 3.64927026 |
| 20 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.63359624 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.56685749 |
| 22 | Glomerulonephritis (HP:0000099) | 3.54889347 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.36744711 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.34202313 |
| 25 | Optic neuritis (HP:0100653) | 3.34202313 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.23247869 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.23247869 |
| 28 | Stomatitis (HP:0010280) | 3.20317575 |
| 29 | Progressive visual loss (HP:0000529) | 3.19831606 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 3.10226633 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.08974860 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.08974860 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.08974860 |
| 34 | Complement deficiency (HP:0004431) | 3.08527526 |
| 35 | Abnormality of macular pigmentation (HP:0008002) | 3.07502207 |
| 36 | Central scotoma (HP:0000603) | 3.02149622 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 3.00319174 |
| 38 | Myocardial infarction (HP:0001658) | 2.95029240 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.90924062 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88067684 |
| 41 | Obstructive lung disease (HP:0006536) | 2.88067684 |
| 42 | Disinhibition (HP:0000734) | 2.86700698 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.86163619 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.83770794 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.81620553 |
| 46 | Nephritis (HP:0000123) | 2.81205209 |
| 47 | Scotoma (HP:0000575) | 2.80408491 |
| 48 | Abnormality of complement system (HP:0005339) | 2.80359191 |
| 49 | Increased IgE level (HP:0003212) | 2.76874138 |
| 50 | Purpura (HP:0000979) | 2.71639140 |
| 51 | Pendular nystagmus (HP:0012043) | 2.71428066 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.71189990 |
| 53 | Loss of speech (HP:0002371) | 2.66469940 |
| 54 | Meningitis (HP:0001287) | 2.65491311 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.62162267 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.60917853 |
| 57 | Cellulitis (HP:0100658) | 2.60620939 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.58638013 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.48651588 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.47271838 |
| 61 | * Vasculitis (HP:0002633) | 2.42896468 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42033709 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.40951685 |
| 64 | Hemoptysis (HP:0002105) | 2.39287125 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39232045 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39232045 |
| 67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38603428 |
| 68 | Macular degeneration (HP:0000608) | 2.37623400 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.36588382 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.36181162 |
| 71 | Gingivitis (HP:0000230) | 2.32587224 |
| 72 | Decreased central vision (HP:0007663) | 2.27986144 |
| 73 | Petechiae (HP:0000967) | 2.27825461 |
| 74 | Pustule (HP:0200039) | 2.27635944 |
| 75 | Increased corneal curvature (HP:0100692) | 2.26422691 |
| 76 | Keratoconus (HP:0000563) | 2.26422691 |
| 77 | Obstructive sleep apnea (HP:0002870) | 2.25553377 |
| 78 | Hematochezia (HP:0002573) | 2.22754086 |
| 79 | Photophobia (HP:0000613) | 2.22269503 |
| 80 | Protrusio acetabuli (HP:0003179) | 2.21523951 |
| 81 | Mutism (HP:0002300) | 2.20262991 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.18733773 |
| 83 | Joint hemorrhage (HP:0005261) | 2.16888378 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 2.16644510 |
| 85 | Epistaxis (HP:0000421) | 2.15975281 |
| 86 | Amyloidosis (HP:0011034) | 2.14512332 |
| 87 | Encephalitis (HP:0002383) | 2.14306060 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.13561944 |
| 89 | Episodic fever (HP:0001954) | 2.13529590 |
| 90 | Xanthomatosis (HP:0000991) | 2.11066696 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.10539344 |
| 92 | Chest pain (HP:0100749) | 2.10429583 |
| 93 | Pulmonary embolism (HP:0002204) | 2.10399888 |
| 94 | Diplopia (HP:0000651) | 2.08688267 |
| 95 | Abnormality of binocular vision (HP:0011514) | 2.08688267 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.06420246 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.05354135 |
| 98 | Deep venous thrombosis (HP:0002625) | 2.03593235 |
| 99 | Colitis (HP:0002583) | 2.03331640 |
| 100 | Peritonitis (HP:0002586) | 2.01625033 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 2.01214634 |
| 102 | Peripheral demyelination (HP:0011096) | 2.00981575 |
| 103 | Pathologic fracture (HP:0002756) | 2.00925287 |
| 104 | Esophageal varix (HP:0002040) | 2.00704298 |
| 105 | Gingival bleeding (HP:0000225) | 2.00399571 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 2.00030052 |
| 107 | Basal ganglia calcification (HP:0002135) | 1.98910752 |
| 108 | Recurrent skin infections (HP:0001581) | 1.98349780 |
| 109 | Cone-rod dystrophy (HP:0000548) | 1.98177003 |
| 110 | Polygenic inheritance (HP:0010982) | 1.96610517 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.95571621 |
| 112 | Nuclear cataract (HP:0100018) | 1.94814094 |
| 113 | Increased serum ferritin (HP:0003281) | 1.94642846 |
| 114 | Broad metatarsal (HP:0001783) | 1.94583652 |
| 115 | Nausea (HP:0002018) | 1.94095707 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.93754049 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.93575259 |
| 118 | Muscle fiber splitting (HP:0003555) | 1.93309604 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 1.92738695 |
| 120 | Choroideremia (HP:0001139) | 1.91801788 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91673284 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91370194 |
| 123 | Papilledema (HP:0001085) | 1.90877025 |
| 124 | Hypercholesterolemia (HP:0003124) | 1.90419833 |
| 125 | Increased IgM level (HP:0003496) | 1.90127359 |
| 126 | T lymphocytopenia (HP:0005403) | 1.89983058 |
| 127 | Increased connective tissue (HP:0009025) | 1.89897985 |
| 128 | Prostate neoplasm (HP:0100787) | 1.89883207 |
| 129 | Cervical subluxation (HP:0003308) | 1.88205548 |
| 130 | Recurrent viral infections (HP:0004429) | 1.88078028 |
| 131 | Myositis (HP:0100614) | 1.87968925 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.87195140 |
| 133 | * Emphysema (HP:0002097) | 1.86910189 |
| 134 | Vertigo (HP:0002321) | 1.86614563 |
| 135 | Urticaria (HP:0001025) | 1.85478918 |
| 136 | Increased CSF protein (HP:0002922) | 1.84854432 |
| 137 | Type II diabetes mellitus (HP:0005978) | 1.84218333 |
| 138 | Aortic aneurysm (HP:0004942) | 1.83779051 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.83701776 |
| 140 | Constricted visual fields (HP:0001133) | 1.83563367 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.82951050 |
| 142 | Acne (HP:0001061) | 1.82321470 |
| 143 | Aortic dissection (HP:0002647) | 1.82156599 |
| 144 | Posterior subcapsular cataract (HP:0007787) | 1.81584684 |
| 145 | Thoracic kyphosis (HP:0002942) | 1.81351515 |
| 146 | Polycythemia (HP:0001901) | 1.81256484 |
| 147 | J-shaped sella turcica (HP:0002680) | 1.81118438 |
| 148 | Shallow orbits (HP:0000586) | 1.80229066 |
| 149 | Conjunctival telangiectasia (HP:0000524) | 1.79607480 |
| 150 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79456289 |
| 151 | Orchitis (HP:0100796) | 1.79136348 |
| 152 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76530341 |
| 153 | Ovoid vertebral bodies (HP:0003300) | 1.76114908 |
| 154 | Vitreoretinal degeneration (HP:0000655) | 1.74420311 |
| 155 | Subcapsular cataract (HP:0000523) | 1.74090428 |
| 156 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73429037 |
| 157 | Osteolytic defects of the hand bones (HP:0009699) | 1.73429037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.73769203 |
| 2 | TRIB3 | 3.74740901 |
| 3 | PRPF4B | 2.87435681 |
| 4 | KIT | 2.81774136 |
| 5 | TBK1 | 2.64928208 |
| 6 | TGFBR2 | 2.56240869 |
| 7 | TTN | 2.55740070 |
| 8 | PBK | 2.22111989 |
| 9 | MAP3K13 | 2.19620360 |
| 10 | RIPK1 | 2.19430562 |
| 11 | GRK1 | 2.16404008 |
| 12 | PKN2 | 2.05565191 |
| 13 | TAOK3 | 1.98444884 |
| 14 | TYK2 | 1.85295154 |
| 15 | PIK3CG | 1.84001019 |
| 16 | IRAK3 | 1.82841871 |
| 17 | TNK2 | 1.79356312 |
| 18 | CAMK1D | 1.76100110 |
| 19 | NEK9 | 1.72593146 |
| 20 | BLK | 1.67195973 |
| 21 | MAP3K14 | 1.66302076 |
| 22 | RIPK4 | 1.59962361 |
| 23 | NME2 | 1.57055267 |
| 24 | SIK1 | 1.50821419 |
| 25 | TAOK1 | 1.49997708 |
| 26 | PTK6 | 1.46776075 |
| 27 | GRK6 | 1.41638700 |
| 28 | MAP2K3 | 1.40138676 |
| 29 | BMX | 1.36525898 |
| 30 | EPHB1 | 1.33851158 |
| 31 | TXK | 1.33219466 |
| 32 | MAP4K1 | 1.32700197 |
| 33 | JAK1 | 1.32022089 |
| 34 | FGR | 1.30650915 |
| 35 | PIM2 | 1.27358751 |
| 36 | RPS6KA4 | 1.25042698 |
| 37 | CDC42BPA | 1.24652055 |
| 38 | TAOK2 | 1.24293282 |
| 39 | ABL2 | 1.21026186 |
| 40 | CAMK1G | 1.18482477 |
| 41 | MARK2 | 1.17275961 |
| 42 | IKBKB | 1.15466677 |
| 43 | PDK2 | 1.14596532 |
| 44 | BTK | 1.13284274 |
| 45 | IRAK4 | 1.11174169 |
| 46 | MAP3K3 | 1.08195158 |
| 47 | TIE1 | 1.08083461 |
| 48 | PRKG2 | 1.07409889 |
| 49 | IKBKE | 1.06390833 |
| 50 | MYLK | 1.04695088 |
| 51 | CSK | 1.04606217 |
| 52 | KDR | 1.04510066 |
| 53 | STK24 | 1.04490590 |
| 54 | TESK1 | 1.01635212 |
| 55 | ZAP70 | 1.01627161 |
| 56 | KSR2 | 1.00005785 |
| 57 | MST1R | 0.98517632 |
| 58 | MAPK12 | 0.94803917 |
| 59 | JAK3 | 0.92526671 |
| 60 | JAK2 | 0.92221630 |
| 61 | HCK | 0.89427460 |
| 62 | PDK1 | 0.87407150 |
| 63 | TESK2 | 0.87338290 |
| 64 | DAPK2 | 0.87087657 |
| 65 | MAP3K11 | 0.84907547 |
| 66 | SIK3 | 0.82855752 |
| 67 | PRKCH | 0.82304314 |
| 68 | FGFR4 | 0.82168221 |
| 69 | STK38L | 0.82125916 |
| 70 | MAP3K7 | 0.81484513 |
| 71 | EPHB2 | 0.81075446 |
| 72 | DMPK | 0.80525856 |
| 73 | PINK1 | 0.80384553 |
| 74 | ITK | 0.80211070 |
| 75 | CHUK | 0.79629785 |
| 76 | PAK4 | 0.79507328 |
| 77 | ARAF | 0.78943765 |
| 78 | MOS | 0.75651717 |
| 79 | PDGFRA | 0.74276734 |
| 80 | MAP3K6 | 0.73950203 |
| 81 | STK3 | 0.73537195 |
| 82 | FES | 0.72277953 |
| 83 | LRRK2 | 0.71125905 |
| 84 | PAK6 | 0.71001530 |
| 85 | HIPK2 | 0.70403742 |
| 86 | CSF1R | 0.70229925 |
| 87 | MAP3K10 | 0.69263285 |
| 88 | MATK | 0.68730778 |
| 89 | BCKDK | 0.65287762 |
| 90 | PIM1 | 0.64748641 |
| 91 | FYN | 0.63935209 |
| 92 | SIK2 | 0.62849081 |
| 93 | PRKD1 | 0.61938355 |
| 94 | MAP3K1 | 0.60844183 |
| 95 | GSK3A | 0.60529686 |
| 96 | MAPK7 | 0.60275698 |
| 97 | PDPK1 | 0.59960992 |
| 98 | CDK12 | 0.58289362 |
| 99 | STK38 | 0.57876280 |
| 100 | PTK2B | 0.56857788 |
| 101 | RPS6KC1 | 0.56633674 |
| 102 | RPS6KL1 | 0.56633674 |
| 103 | RPS6KA2 | 0.56095083 |
| 104 | MARK3 | 0.55271045 |
| 105 | ABL1 | 0.54781069 |
| 106 | CASK | 0.53999812 |
| 107 | MAP2K6 | 0.53624935 |
| 108 | EGFR | 0.53315078 |
| 109 | MAPK4 | 0.51319391 |
| 110 | PRKD3 | 0.50928045 |
| 111 | PTK2 | 0.50020543 |
| 112 | CDK6 | 0.49916348 |
| 113 | FGFR3 | 0.49108107 |
| 114 | CAMK1 | 0.48425482 |
| 115 | SGK3 | 0.48247020 |
| 116 | GRK5 | 0.48223521 |
| 117 | CAMKK1 | 0.48208552 |
| 118 | DAPK3 | 0.48101497 |
| 119 | LATS1 | 0.47219164 |
| 120 | PRKD2 | 0.46884780 |
| 121 | PAK2 | 0.46746325 |
| 122 | PRKAA2 | 0.46471000 |
| 123 | PDGFRB | 0.45910383 |
| 124 | RPS6KA6 | 0.45258652 |
| 125 | FLT3 | 0.45098129 |
| 126 | GRK7 | 0.44895848 |
| 127 | STK10 | 0.44401268 |
| 128 | IRAK2 | 0.44256393 |
| 129 | CAMKK2 | 0.43979737 |
| 130 | DYRK1B | 0.42354873 |
| 131 | SYK | 0.41393950 |
| 132 | MAP2K2 | 0.41181682 |
| 133 | CAMK4 | 0.40728867 |
| 134 | DDR2 | 0.40317490 |
| 135 | TYRO3 | 0.40119210 |
| 136 | LCK | 0.39868186 |
| 137 | EPHA3 | 0.39759260 |
| 138 | LYN | 0.38868547 |
| 139 | RET | 0.38856846 |
| 140 | BMPR2 | 0.38223831 |
| 141 | MAP3K5 | 0.37487936 |
| 142 | TRPM7 | 0.37257450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.21942716 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.37053711 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.08888443 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.01362269 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23128799 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09472243 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07805110 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.07632594 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97209943 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88141075 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86283866 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.85113841 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61817797 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.58265443 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.57038093 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.51323246 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49212358 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47986848 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47198759 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.41773223 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38301587 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36916768 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36802714 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28279298 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24442833 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.19704393 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13552815 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13532046 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10633762 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06850934 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06020946 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.05675616 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04607865 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04459475 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99515621 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.96524521 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93826392 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92826729 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91604677 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89974451 |
| 41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89944491 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88322254 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.86512819 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.86134346 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86127147 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84397333 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.83651609 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82391497 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81838259 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81785260 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81663762 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81340542 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77585192 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75598112 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74895909 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72844637 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.72807396 |
| 58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70434554 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.70432890 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.70301675 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.69306170 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68998360 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68342534 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67681560 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67027219 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65841887 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65823589 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65180862 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64003219 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63809945 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63679843 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62848957 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62441840 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62400254 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61406037 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60365930 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60362072 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60301392 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.58646279 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57556406 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.57393783 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.57200125 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57044626 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55742986 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55647357 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.54749313 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54530857 |
| 88 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54311185 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53560770 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53088857 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.52528361 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52304076 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51428831 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.51257268 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50444566 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.50387257 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50349934 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49856880 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49821205 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.49670217 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49285170 |
| 102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49091335 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48591254 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48480840 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47639775 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47097807 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47097196 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46926997 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46722652 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46413355 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46378528 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46287940 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43751275 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43653398 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.43141953 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42821554 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.42480222 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42247596 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42066085 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41633882 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39775663 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.39704378 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39668932 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39666576 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38792619 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38341809 |
| 127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38141429 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37794856 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37526628 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37410442 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37261668 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36651497 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35920572 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34870393 |

